A clinical gene vaccine to combat a severe respiratory disease has been developed in a cooperation between Penn and Sun Yat-sen University in Guangzhou, China.
The vaccine, the first gene vaccine for severe acute respiratory syndrome, is expected to be launched pending additional testing. It has already been tested on animals and was researched at Penn. SARS, an infectious disease, was found in parts of Asia and across the world in 2003. In addition to the SARS vaccine, the joint project is intended to work on vaccines against AIDS, avian flu and other epidemics.
